Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
about
DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLFUroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyriaLiver-specific expression of the human factor VII geneThe C/EBP family of transcription factors in the liver and other organs.D-site binding protein transactivation requires the proline- and acid-rich domain and involves the coactivator p300.Haemophilia B (sixth edition): a database of point mutations and short additions and deletionsHaemophilia B: database of point mutations and short additions and deletions--eighth edition.Genetic sequence analysis of inherited bleeding diseases.Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationTranscriptional regulation of the gene coding for human protein C.An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B LeydenOrthogonal analysis of C/EBPbeta targets in vivo during liver proliferation.Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter.Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.Haemophilia B: database of point mutations and short additions and deletions, 7th edition.Regulation of the human protein S gene promoter by liver enriched transcription factors.Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapy.Gene therapy expression vectors based on the clotting Factor IX promoter.Role of intron I in expression of the human factor IX gene.The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide.Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.Androgen effects on factor IX expression: in-vitro and in-vivo studies in mice.
P2860
Q24609997-1DB30F00-2963-4C71-A61C-2049D0FB81F3Q28360504-8D9A8009-E953-4D08-BE05-C61B05942145Q28610828-2C70D3B9-F24D-4095-AB75-C48E56152074Q33630431-80D0E19F-3E39-41EE-8082-44AAFA963E5BQ33864495-9917E9AF-167F-44B1-BFB3-038D4BBEF93FQ34587135-303498DB-C7B1-440C-BD5A-ACE2BF3E31B2Q34646217-E5FB527E-59AD-4869-B35A-8BDC9464D8E2Q34663589-58AA7022-EED7-4067-B0C4-4721C9DA872CQ34868581-34F5C4EE-27AC-4ACA-B86B-251D5FDDDE4DQ36558883-748B82AE-1E74-4F62-943A-79181C9BF315Q36798033-9E85FD9F-BCAA-4149-A590-3874DCA76D8CQ37172394-6F3B8756-2E9D-4DFD-937E-0595699ABA2FQ37512283-F47CFD13-D370-42EB-BEDC-4C249BDD7183Q38291133-98C88FE3-3E4A-4D75-9826-4BDB17075C44Q38358525-06887E0D-538C-4ED6-8BFB-E2E971319B02Q39718530-9BDBAB93-CAE8-4AFA-87C1-7BFE6F869BF9Q40216318-F2C3C665-1851-4795-A23B-05A4338266B8Q40588297-19AD7AD6-E959-477E-BA5D-2391924CF1C2Q40928425-B5144268-57A7-491F-93EF-5DFBB559E949Q41360681-5BC4F015-8488-48D2-A874-940B82AC43CCQ45868984-778B5A8B-FFCC-4765-B35A-A474662E3453Q45873503-47CBDA6A-37EE-48AD-B5B2-40E8EE9F399EQ45887434-FBE786D2-46E4-42D7-B128-A4B2A35C0310
P2860
Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Synergy between transcription ...... a B Leyden factor IX mutation.
@ast
Synergy between transcription ...... a B Leyden factor IX mutation.
@en
Synergy between transcription ...... a B Leyden factor IX mutation.
@nl
type
label
Synergy between transcription ...... a B Leyden factor IX mutation.
@ast
Synergy between transcription ...... a B Leyden factor IX mutation.
@en
Synergy between transcription ...... a B Leyden factor IX mutation.
@nl
prefLabel
Synergy between transcription ...... a B Leyden factor IX mutation.
@ast
Synergy between transcription ...... a B Leyden factor IX mutation.
@en
Synergy between transcription ...... a B Leyden factor IX mutation.
@nl
P2093
P2860
P921
P356
P1433
P1476
Synergy between transcription ...... a B Leyden factor IX mutation.
@en
P2093
Lillicrap DP
Mueller CR
Picketts DJ
P2860
P2888
P304
P356
10.1038/NG0293-175
P407
P577
1993-02-01T00:00:00Z